Skip Navigation

Strengthen the Evidence for Maternal and Child Health Programs

Sign up for MCHalert eNewsletter

Search Results: MCHLine

Items in this list may be obtained from the sources cited. Contact information reflects the most current data about the source that has been provided to the MCH Digital Library.

Displaying records 1 through 5 (5 total).

U.S. Substance Abuse and Mental Health Services Administration. 2018. Clinical guidance for treating pregnant and parenting women with opioid use disorder and their infants. Rockville, MD: U.S. Substance Abuse and Mental Health Services Administration, 159 pp.

Annotation: This guide provides guidance for the optimal management of pregnant and parenting women with opioid use disorder (OUD) and their infants, based on recommendations of experts as of 2017. The guide is designed to help health professionals and women determine the most clinically appropriate action for a particular circumstance. In addition to offering background information, the guide includes fact sheets divided into the following sections: prenatal care, infant care, and maternal postnatal care. Each fact sheet includes a clinical scenario, clinical action steps, supporting evidence and clinical considerations, and links to and descriptions of online resources on the topic.

Contact: U.S. Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane , Rockville, MD 20857, Telephone: (877) SAMHSA-7 Secondary Telephone: (877) 726-4727 E-mail: Web Site: https://www.samhsa.gov Available from the website. Document Number: (SMA) 18-5054. .

Keywords: Guidelines, Narcotics, Parents, Perinatal addiction, Pregnant women, Prenatal addiction, Substance dependence, Substance use disorders, Treatment

National Institute for Health Care Management Foundation. 2015. Reducing neonatal abstinence syndrome in Tennessee. Washington, DC: National Institute for Health Care Management Foundation, 2 pp. (Women, children & adolescents)

Annotation: This fact sheet highlights partnerships to address the neonatal abstinence syndrome (NAS) epidemic in Tennessee. Topics include efforts to expand a community-based program to assist mothers with substance abuse problems and ensure a drug-free and safe home for their newborns; provide start-up costs for a regional detox center for women addicted to prescription drugs; research the effectiveness of detox from opiate drugs during pregnancy, and the long-term effect of detox treatment on NAS rates in the state; and establish a hospital-based NAS treatment process.

Contact: National Institute for Health Care Management Foundation, 1225 19th Street, N.W., Suite 710, Washington, DC 20036, Telephone: (202) 296-4426 Fax: (202) 296-4319 E-mail: http://www.nihcm.org/contact Web Site: http://www.nihcm.org Available from the website.

Keywords: Drug addiction, Drug use during pregnancy, Financing, Neonatal abstinence syndrome, Newborn infants, Opiates, Postpartum care, Pregnant women, Prenatal care, Prevention program, State initiatives, Substance abuse treatment, Tennessee

FASD Regional Training Centers, Centers for Disease Control and Prevention, and National Organization on Fetal Alcohol Syndrome. [2008]. Fetal alcohol spectrum disorders: Competency-based curriculum development guide for medical and allied health education and practice. Atlanta, GA: Centers for Disease Control and Prevention, ca. 280 pp., 1 CD-ROM.

Annotation: This purpose of this curriculum development guide is to enhance the knowledge and skills of health care providers to recognize and prevent fetal alcohol spectrum (FAS) disorders by aiding in the development of educational programs and materials. The guide is organized by three types of learning outcomes: competencies, learning goals, and learning objectives, allowing educators or trainers to select goals and objectives appropriate for participants' learning needs and skill levels, along with university or organization criteria. Chapter contents include seven competency topics: foundation; screening and brief interventions; models of addiction; biological effects of alcohol on the fetus; screening, diagnosis, and assessment of FAS; treatment across the lifespan for persons with FASDs; and ethical, legal, and policy issues.

Contact: Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30329-4027, Telephone: (800) 232-4636 Secondary Telephone: (888) 232-6348 E-mail: https://www.cdc.gov/cdc-info/forms/contact-us.html Web Site: http://www.cdc.gov Available from the website.

Keywords: Alcohol use during pregnancy, CD-ROMs, Fetal alcohol effects, Fetal alcohol syndrome, Fetal development, Prenatal addiction, Prenatal care, Professional education, Resources for professionals, Screening, Substance abusing pregnant women

SAMHSA Fetal Alcohol Spectrum Disorders Center for Excellence. 2005. Hope for women in recovery: Understanding and addressing the impact of prenatal alcohol exposure. Rockville, MD: SAMHSA Fetal Alcohol Spectrum Disorders Center for Excellence, 24 pp.

Annotation: This report presents information from the summit, Hope for Women in Recovery: Understanding and Addressing the Impact of Prenatal Alcohol Exposure, held on July 21-22, 2005, in Raleigh, North Carolina. The summit was designed to educate women of childbearing age in recovery and substance abuse treatment center staff about fetal alcohol spectrum disorders. The report includes information from presentations held at the summit, including personal stories of women in recovery and presentations by health professionals.

Contact: SAMHSA Fetal Alcohol Spectrum Disorders Center for Excellence, 2101 Gaither Road, Suite 600, Rockville, MD 20850, Telephone: (866) 786-7327 E-mail: [email protected] Web Site: http://www.fasdcenter.samhsa.gov/ Available from the website.

Keywords: Alcohol consumption during pregnancy, Education, Fetal alcohol syndrome, Perinatal addiction, Perinatal health, Personal narratives, Prenatal addiction, Recovering addicts, Recovering alcoholics, Substance abuse treatment, Substance abusing pregnant women, Women', s health

Peck M, ed. 1990. What works: 1990 urban MCH programs, a directory of maternal and child health programs in major urban health departments. Omaha, NE: University of Nebraska Medical Center, CityMatCH, 91 pp.

Annotation: This directory is based on the 1990 Followup Survey of Maternal and Child Health in Major Urban Health Departments in the United States conducted by the CityMatCH Project. The directory includes current information about MCH programs in urban health departments across the country and is designed to assist public health practitioners and others who are concerned about the status of maternal and child health at the local level. Background information about the CityMatCH Project and survey methods are presented in the first chapter. An overview of survey findings across all responding health departments is given in the second chapter. The third chapter provides descriptions of successful MCH initiatives and strategies, including initiatives on prenatal care, perinatal substance abuse, infant mortality reduction, postneonatal mortality reduction, and child health. Contact information for major urban MCH programs and their leaders is listed in the fourth chapter. [Funded by the Maternal and Child Health Bureau]

Contact: Maternal and Child Health Library at Georgetown University, E-mail: [email protected] Web Site: https://www.mchlibrary.org Available from the website. Document Number: HRSA Info. Ctr. MCHD084.

Keywords: City health agencies, Infant mortality, Perinatal addiction, Prenatal care, Substance abuse
   

The MCH Digital Library is one of six special collections at Geogetown University, the nation's oldest Jesuit institution of higher education. It is supported in part by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under award number U02MC31613, MCH Advanced Education Policy with an award of $700,000/year. The library is also supported through foundation and univerity funding. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.